Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2025-12-17 00:00:00 ET · period of report 2025-12-15 · accession 0001608936-25-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-17 | 2025-12-16 | ORIC | Chacko Jacob | Pres AND CEO, Dir | S - Sale+OE | $9.06 | -33.4K | 581.7K | -5% | -$302.4K |
| D | 2025-12-17 | 2025-12-15 | ORIC | Chacko Jacob | Pres AND CEO, Dir | M - OptEx | $0.00 | +83.7K | 615.1K | +16% | $0 |
| DM | 2025-12-17 | 2025-12-15 | ORIC | Chacko Jacob | Pres AND CEO, Dir | M - OptEx | $0.00 | -83.7K | 28.3K | -75% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-16 | S | D | 33,374 | $9.06 | 581,711 | D | — | — | (F3) Represents the weighted average share price of an aggregate total of 33,374 shares sold in the price range of $9.0257 to $9.095 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-12-15 | M | A | 83,666 | $0.00 | 615,085 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. |
| 3 | Derivative | Restricted Stock Unit | 2025-12-15 | M | D | 33,333 | $0.00 | 66,667 | D | — · — to — | 33,333 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. (F6) 1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027. |
| 4 | Derivative | Restricted Stock Unit | 2025-12-15 | M | D | 22,000 | $0.00 | 0 | D | — · — to — | 22,000 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. (F4) 1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025. |
| 5 | Derivative | Restricted Stock Unit | 2025-12-15 | M | D | 28,333 | $0.00 | 28,334 | D | — · — to — | 28,333 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. (F5) 1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026. |